Review



matriptase  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    R&D Systems matriptase
    Matriptase, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/matriptase/product/R&D Systems
    Average 95 stars, based on 27 article reviews
    matriptase - by Bioz Stars, 2026-04
    95/100 stars

    Images



    Similar Products

    matriptase  (R&D Systems)
    95
    R&D Systems matriptase
    Matriptase, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/matriptase/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    matriptase - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    recombinant human matriptase st14 catalytic domain  (R&D Systems)
    95
    R&D Systems recombinant human matriptase st14 catalytic domain
    Recombinant Human Matriptase St14 Catalytic Domain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human matriptase st14 catalytic domain/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    recombinant human matriptase st14 catalytic domain - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    human matriptase  (R&D Systems)
    95
    R&D Systems human matriptase
    Structures of the masking reagent consist of: 1) a maleimide for conjugation, 2) a <t>matriptase‐cleavable</t> peptide (highlighted in purple), and 3) PEG to create steric hindrance, preventing the antibody from binding to the target.
    Human Matriptase, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human matriptase/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    human matriptase - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    recombinant human matriptase  (R&D Systems)
    95
    R&D Systems recombinant human matriptase
    Structures of the masking reagent consist of: 1) a maleimide for conjugation, 2) a <t>matriptase‐cleavable</t> peptide (highlighted in purple), and 3) PEG to create steric hindrance, preventing the antibody from binding to the target.
    Recombinant Human Matriptase, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human matriptase/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    recombinant human matriptase - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    human st14 protease catalytic domain  (R&D Systems)
    95
    R&D Systems human st14 protease catalytic domain
    Structures of the masking reagent consist of: 1) a maleimide for conjugation, 2) a <t>matriptase‐cleavable</t> peptide (highlighted in purple), and 3) PEG to create steric hindrance, preventing the antibody from binding to the target.
    Human St14 Protease Catalytic Domain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human st14 protease catalytic domain/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    human st14 protease catalytic domain - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    gly596 to val855  (R&D Systems)
    95
    R&D Systems gly596 to val855
    Structures of the masking reagent consist of: 1) a maleimide for conjugation, 2) a <t>matriptase‐cleavable</t> peptide (highlighted in purple), and 3) PEG to create steric hindrance, preventing the antibody from binding to the target.
    Gly596 To Val855, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gly596 to val855/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    gly596 to val855 - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    recombinant human st14  (R&D Systems)
    95
    R&D Systems recombinant human st14
    Structures of the masking reagent consist of: 1) a maleimide for conjugation, 2) a <t>matriptase‐cleavable</t> peptide (highlighted in purple), and 3) PEG to create steric hindrance, preventing the antibody from binding to the target.
    Recombinant Human St14, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human st14/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    recombinant human st14 - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Structures of the masking reagent consist of: 1) a maleimide for conjugation, 2) a matriptase‐cleavable peptide (highlighted in purple), and 3) PEG to create steric hindrance, preventing the antibody from binding to the target.

    Journal: Chembiochem

    Article Title: Design and Characterization of Prodrugged Anti‐CTLA‐4 Antibodies

    doi: 10.1002/cbic.202500304

    Figure Lengend Snippet: Structures of the masking reagent consist of: 1) a maleimide for conjugation, 2) a matriptase‐cleavable peptide (highlighted in purple), and 3) PEG to create steric hindrance, preventing the antibody from binding to the target.

    Article Snippet: Prodrugged antibody was incubated with human matriptase (30:1 molar ratio, R&D system, 3946‐SE‐010) in 100 mM Tris buffer, pH7.6 at 37C.

    Techniques: Conjugation Assay, Binding Assay